Life Science

Asthma care boost from organisations nurtured by Milton-based healthcare organisation

Deal expands the Cambridge life science firm's custom capabilities

'Open, porous, collaborative' place will help bolster UK life sciences, says senior executive

An interview with CEO Dr Chibeza Agley as Cambridge company secures investment for its OBRIZUM platform

We tour the striking building that could redefine what a pharma business looks like

Companies sign agreement for Lightning-Link Rapid Biotin technology

Next-generation immuno-oncology candidate triggers AstraZeneca payment

Dr Mene Panaglos explains how a change in culture led to dramatic results for the pharmaceutical company

Company says it is preparing for no-deal Brexit

CEO Pascal Soriot says company expects 'sustained growth' period as new R&D units and commercial units created

Genomics data compression firm was spun out of university in 2016

The biopharmaceutical company is teaming up with CRUK on a Functional Genomics Centre in Cambridge

Pulmonary arterial hypertension (PAH) investment for preclinical trials of disease-modifying MGX292 drug candidate

The first bio-incubator programme at the campus has given some exciting companies a significant boost

Cambridge-based Congenica underpins genomic service

The Functional Genomics Centre on Cambridge Biomedical Campus aims to improve our understanding of cancer biology

"It's about changing the narrative from reactive to proactive" said Rebecca Pinder at RAREfest

Biopharmaceutical companies among winners for major deals

'We have found our tribe', say families at rare disease weekend

Cambridge non-profit teams up with Coko, open-access publisher Hindawi Limited and digital consultancy Digirati